Option Care Health, Inc. (OPCH)
NEUTRALFundamental
72
Precio
$23.36
Capitalización Bursátil
$3.58B
Parte 1 · Cuánto vale la empresa
Resumen
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance y Liquidez
Ingresos
$5.67B
Últimos 12 meses (hasta 31/3/2026)
Beneficio Neto
$206M
Últimos 12 meses (hasta 31/3/2026)
Flujo de Caja Libre
$217M
Patrimonio Neto Total
$1.33B
Pasivo Total
$2.13B
Ratio de Liquidez
1.64
Cobertura de Intereses
6.06
Deuda/EBITDA
3.13
Beneficio Por Acción
Ingresos y Beneficio Neto
Flujo de Caja Libre
Desglose de Ingresos
Estado histórico
Márgenes en el tiempo
La deuda en el tiempo
Cuánto pesa la deuda
Cuadro de crecimiento
Crecimiento — Ingresos
Estimación de Valor Justo
Valor Justo
$30.30
Precio Actual
$23.36
Margen de Seguridad
+22.9%
Rango de Valor Justo
$19.70 - $40.91
Métodos de Estimación
Métricas de Valoración
Ratio P/E
18.49
ROE
15.7%
Ratio P/B
2.75
P/FCF
17.49
Margen Bruto
19.2%
ROIC
9.9%
Radar de Rentabilidad
Value Creation (Economic Moat)
ROIC
9.9%
WACC
6.8%
ROIC − WACC
+3.1 pp
ROIC exceeds the cost of capital — the company is creating value for shareholders.
Criterios de Análisis Fundamental
Superado (20)
- EPS shows upward trend
- EPS CAGR 15.84%
- Price CAGR 19.01%
- ROIC 9.9%
- P/FCF 17.49
- P/B Ratio 2.75
- Debt/Equity ratio
- Operating Margin 5.8%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 15.8%
- Revenue Growth 5Y 13.3%
- Analyst Consensus 68% Buy
- Earnings Quality (OCF/NI) 1.23
- Share Dilution -5.1%
- Piotroski F-Score 5/9
Fallido (6)
- Gross Margin 19.2%
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Earnings Surprise avg 2.4%
- Net Margin Trend 3.6% vs 4.1%
No disponible (2)
- Dividend Payout NaN%
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
Señales mixtas: algunas áreas requieren atención
Calidad de los Beneficios
Alta calidad: beneficios respaldados por efectivo
Dilución de Acciones
Recomprando acciones. Favorable para el accionista
Gobernanza
Equipo Directivo
| Nombre | Cargo | Edad |
|---|---|---|
| Mr. John Charles Rademacher | CEO, President & Director | 58 |
| Mr. Luke Whitworth | Chief Operating Officer | 44 |
| Mr. Collin G. Smyser | General Counsel & Corporate Secretary | 46 |
| Ms. Nicole Maggio | Senior VP, Controller & Principal Accounting Officer | 42 |
| Mr. Brett Michalak | Chief Technology Officer | - |
| Ms. Alyssa Moy | Chief Information Officer | - |
| Ms. Stacey Mahone | Senior VP & Chief Compliance Officer | - |
| Mr. Jorge Ramirez | Senior VP of Strategy and Corporate Development | - |
| Mr. Michael Bavaro | Chief Human Resources & Chief Diversity Officer | 47 |
| Ms. Julie Koenig | Senior Vice President of Operations | - |
Riesgo de Auditoría
1
Riesgo del Consejo
2
Riesgo de Compensación
4
Riesgo de Derechos del Accionista
5
Parte 2 · El precio y el momento de entrar
Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.
Latest News
Recent headlines for OPCH, sourced from Markets Gazette.
- 2/24/2026NEUTRALOption Care (OPCH) Earnings Call Transcript
Investors in Option Care Health (OPCH) are awaiting the release of the earnings call transcript, scheduled for February 24, 2026. While the specific content is not yet available, this event is crucial for understanding the company's financial performance and future outlook. Earnings calls provide detailed insights into revenues, profits, margins, and guidance, which are fundamental elements for assessing a company's operational and strategic health. The analysis of this data will enable analysts and shareholders to make informed judgments about the stock's short- to medium-term trajectory. The current lack of content implies a waiting period for the market, which will react once the information is made public.
via Markets Gazette